These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30611536)

  • 41. Big data in pharmacogenomics: current applications, perspectives and pitfalls.
    Barrot CC; Woillard JB; Picard N
    Pharmacogenomics; 2019 Jun; 20(8):609-620. PubMed ID: 31190620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
    Olivera GG; Urtasun A; Sendra L; Aliño SF; Yáñez Y; Segura V; Gargallo P; Berlanga P; Castel V; Cañete A; Herrero MJ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenomics: personalizing pediatric heart transplantation.
    Van Driest SL; Webber SA
    Circulation; 2015 Feb; 131(5):503-12. PubMed ID: 25645611
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacogenomics and personalized medicine in clinical practice.
    Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
    Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human genetics: international projects and personalized medicine.
    Apellaniz-Ruiz M; Gallego C; Ruiz-Pinto S; Carracedo A; Rodríguez-Antona C
    Drug Metab Pers Ther; 2016 Mar; 31(1):3-8. PubMed ID: 26581075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines.
    Ramamoorthy A; Karnes JH; Finkel R; Blanchard R; Pacanowski M
    Clin Transl Sci; 2019 Nov; 12(6):560-563. PubMed ID: 31444855
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
    Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetics and variable drug response.
    Wilke RA; Dolan ME
    JAMA; 2011 Jul; 306(3):306-7. PubMed ID: 21771992
    [No Abstract]   [Full Text] [Related]  

  • 51. [Personalized medicine and individual healthcare : Medical and information technology aspects].
    Niederlag W; Lemke HU; Rienhoff O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):776-82. PubMed ID: 20700776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precision medicine: generating real-world evidence for companion diagnostics.
    Horn EJ; Terry SF
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):75-6. PubMed ID: 22335828
    [No Abstract]   [Full Text] [Related]  

  • 53. Editorial: pharmacogenetics and molecular medicine: "so close and yet so far".
    Moore JH; Hwa J
    Curr Mol Med; 2014; 14(7):803-4. PubMed ID: 25109800
    [No Abstract]   [Full Text] [Related]  

  • 54. From genomes to genomic medicine: enabling personalized and precision medicine in the Middle East.
    Jithesh PV; Scaria V
    Per Med; 2017 Sep; 14(5):377-382. PubMed ID: 29754564
    [No Abstract]   [Full Text] [Related]  

  • 55. What is personalized medicine and what should it replace?
    Whitcomb DC
    Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):418-24. PubMed ID: 22614753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
    Grossman I; Knappertz V; Laifenfeld D; Ross C; Zeskind B; Kolitz S; Ladkani D; Hayardeny L; Loupe P; Laufer R; Hayden M
    Prog Neurobiol; 2017 May; 152():114-130. PubMed ID: 26952809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Institutional profile: University of Florida Health Personalized Medicine Program.
    Cavallari LH; Weitzel KW; Elsey AR; Liu X; Mosley SA; Smith DM; Staley BJ; Winterstein AG; Mathews CA; Franchi F; Rollini F; Angiolillo DJ; Starostik P; Clare-Salzler MJ; Nelson DR; Johnson JA
    Pharmacogenomics; 2017 Apr; 18(5):421-426. PubMed ID: 28346068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toward dynamical systems medicine: personalized and preventive strategies.
    Yan Q
    Per Med; 2017 Sep; 14(5):551-554. PubMed ID: 29754568
    [No Abstract]   [Full Text] [Related]  

  • 60. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.